|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 345.38 USD | -0.14% |
|
-0.08% | +2.41% |
| Jan. 13 | Baird Adjusts Cencora Price Target to $415 From $392, Maintains Outperform Rating | MT |
| Jan. 12 | Cencora, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:00 AM |
| Capitalization | 67.1B 57.66B 53.77B 49.96B 93.22B 6,060B 101B 618B 243B 2,896B 252B 246B 10,680B | P/E ratio 2026 * |
24.3x | P/E ratio 2027 * | 21.2x |
|---|---|---|---|---|---|
| Enterprise value | 68.29B 58.68B 54.72B 50.85B 94.87B 6,167B 102B 629B 247B 2,947B 256B 251B 10,869B | EV / Sales 2026 * |
0.2x | EV / Sales 2027 * | 0.18x |
| Free-Float |
35.16% | Yield 2026 * |
0.66% | Yield 2027 * | 0.69% |
Last Transcript: Cencora, Inc.
| 1 day | -0.14% | ||
| 1 week | -0.08% | ||
| Current month | +2.41% | ||
| 1 month | -0.03% | ||
| 3 months | +9.11% | ||
| 6 months | +17.16% | ||
| Current year | +2.41% |
| 1 week | 333.79 |  | 349.02 |
| 1 month | 329.1 | | 351.99 |
| Current year | 329.1 | | 349.55 |
| 1 year | 236.37 | | 377.54 |
| 3 years | 147.48 | | 377.54 |
| 5 years | 100.71 | | 377.54 |
| 10 years | 68.38 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 2024-09-30 |
James Cleary
DFI | Director of Finance/CFO | 63 | 2018-11-08 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 2013-05-15 |
Robert Mauch
BRD | Director/Board Member | 59 | 2024-09-30 |
D. Mark Durcan
CHM | Chairman | 64 | 2025-09-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.14% | -0.08% | +46.50% | +110.54% | 67.1B | |
| -0.33% | -2.72% | +9.82% | +9.51% | 216B | |
| -0.12% | -3.88% | +17.89% | +19.64% | 124B | |
| +0.11% | -1.87% | -14.68% | -21.24% | 57.41B | |
| +4.93% | +3.49% | +28.21% | +98.13% | 52.63B | |
| -2.28% | +7.74% | - | - | 35.66B | |
| -0.46% | +0.52% | -12.01% | -35.24% | 27.4B | |
| -0.11% | -0.06% | +25.32% | +28.63% | 25.51B | |
| +0.05% | -3.68% | +6.34% | -33.52% | 24.31B | |
| +0.35% | +0.26% | -23.84% | +28.74% | 21.04B | |
| Average | +0.22% | -0.15% | +9.28% | +22.80% | 65.08B | |
| Weighted average by Cap. | +0.16% | -1.32% | +13.11% | +25.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 341B 293B 273B 254B 473B 30,763B 510B 3,138B 1,233B 14,701B 1,277B 1,251B 54,219B | 363B 312B 291B 270B 504B 32,764B 543B 3,342B 1,313B 15,657B 1,361B 1,333B 57,746B |
| Net income | 2.39B 2.05B 1.91B 1.78B 3.32B 216B 3.58B 22.01B 8.65B 103B 8.96B 8.78B 380B | 3.12B 2.68B 2.5B 2.33B 4.34B 282B 4.68B 28.78B 11.31B 135B 11.72B 11.48B 497B |
| Net Debt | 1.19B 1.02B 952M 885M 1.65B 107B 1.78B 10.95B 4.3B 51.29B 4.46B 4.37B 189B | -1.1B -945M -881M -819M -1.53B -99.33B -1.65B -10.13B -3.98B -47.47B -4.12B -4.04B -175B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-13 | 345.88 $ | +1.09% | 1,163,056 |
| 26-01-12 | 342.16 $ | +1.93% | 1,013,173 |
| 26-01-09 | 335.69 $ | -0.01% | 916,997 |
| 26-01-08 | 335.74 $ | -1.37% | 1,133,960 |
| 26-01-07 | 340.41 $ | -1.66% | 988,680 |
Delayed Quote Nyse, January 13, 2026 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
